Global Breast Imaging Equipment Market Size study & Forecast, by Product Type (Tomosynthesis, Breast Ultrasound, Breast MRI, Mammography, Nuclear Imaging, Bioelectric Imaging, Breast Thermography) and Regional Analysis, 2022-2029

Global Breast Imaging Equipment Market Size study & Forecast, by Product Type (Tomosynthesis, Breast Ultrasound, Breast MRI, Mammography, Nuclear Imaging, Bioelectric Imaging, Breast Thermography) and Regional Analysis, 2022-2029

Global Breast Imaging Equipment Market is valued at approximately USD XX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XX% over the forecast period 2022-2029. Breast imaging is a method for obtaining a high-resolution visual of the breast and disorders associated with the breast. The most typical malignancy found in women is breast cancer. Breast imaging techniques are crucial for making an early diagnosis, monitoring the disease's progression, and selecting the best course of treatment. With the use of this imaging tool, doctors can keep track of a patient's response to treatment and its effectiveness. The current screening method relies on nuclear imaging, mammography, ultrasound, MRI, and thermography. The rising incidences of breast cancer coupled with the growing number of geriatric individuals are key factors driving the market growth.

The rising incidences of breast cancer are contributing towards the growth of the Global Breast Imaging Equipment Market. For instance – As per Breast Cancer Research Foundation (BCRF)- in 2020, about 2.3 million women were diagnosed with breast cancer worldwide and 685,000 lost their lives due to breast cancer. Furthermore, as per International Agency for Research on Cancer (IARC) – in 2020, in North America the total number of breast cancer cases was estimated at 281000, and this number is projected to grow to 316000 in 2030. Moreover, another factor driving the market growth is the rising number of geriatric individuals, as per the National Institute of Health (NIH) – breast cancer risk increases with age and about a third of female breast cancers are diagnosed in patients aged older than 70. For instance - according to the World Bank Group, the world old population was 727 million in 2020, and it is predicted to treble over the next three decades, reaching 1.5 billion in 2050. Also, the growing development of healthcare infrastructure as well as the rising adoption of early screening techniques would create lucrative growth opportunities for the market over the projected period. However, the high manufacturing cost associated with Imaging Equipment hinders the market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Breast Imaging Equipment Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the dominance of leading market players as well as the increasing prevalence of breast cancer in the region. Whereas Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as rising geriatric and target populations, and the growing expansion of healthcare infrastructure in the region.

Major market player included in this report are:
Hologic Inc.
GE Healthcare
Gamma Medica
Siemens AG
Dilon Technologies
Toshiba Corporation
Aurora Imaging Technology Inc.
Siemens Healthcare GmbH
Seno Medical
Koninklijke Philips N.V.

Recent Developments in the Market:
 In March 2021, Siemens Healthineers announced the launch of a new software solution Mammovista B.smart that is based on AI technology and boosts the breast image reading process, tracks, and analyses the workflow. It reduces the loading time and enables the radiologist in reading the number of patient databases.

 In February 2021, US-based Smart Breast, a leader in molecular breast imaging devices acquired GE Healthcare’s Discovery NM750b Molecular breast imaging portfolio. This acquisition would strengthen the product portfolio of Smart Breast.

Global Breast Imaging Equipment Market Report Scope:
Historical Data 2019-2020-2021
Base Year for Estimation 2021
Forecast period 2022-2029
Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered Product Type, Region
Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope Free report customization (equivalent up to 8 analyst’s working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players.

The detailed segments and sub-segment of the market are explained below:

By Product Type
Tomosynthesis
Breast Ultrasound
Breast MRI
Mammography
Nuclear Imaging
Bioelectric Imaging
Breast Thermography

By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World

Companies Mentioned

Hologic Inc.
GE Healthcare
Gamma Medica
Siemens AG
Dilon Technologies
Toshiba Corporation
Aurora Imaging Technology Inc.
Siemens Healthcare GmbH
Seno Medical
Koninklijke Philips N.V.

Please note:The single user license is non-downloadable and non-printable. Global Site license allows these actions.